We talk supplementation, neurotech, mitochondrial dysfunction, clinical scale-ups, COVID and CGM with Longevity legend: Dave Asprey
Ahead of Revolution Against Aging and Death conference, which...
Teenage founder of Canadian start-up Biotein hunts a universal phenotype for senescent cells.
As we’ve covered in the past, Biotein’s Nina Khera has a mission...
BioViva and Integrated Health Systems: How many patients in trials? Where are they located? What pipeline stage?
As we've covered in the past, BioViva's Liz...
Forever Healthy Foundation issues risk-benefit analysis on dasatinib + quercetin as a senolytic.
The Forever Healthy Foundation published its latest risk-benefit analysis, which explores the combined...
After $0.5bn cumulative investment, Human Longevity Inc. pivots into high-end medical services to seek scale and ROI.
For a few years we tracked Human Longevity Inc.'s...
Tracked.bio develops AI computer vision system that tracks flies and mice to reduce man-hours and increase data collected in Longevity studies.
A Danish start-up aims...
Bigger certainly doesn't mean better when it comes to Quicksilver's nutraceutical delivery methods.
The COVID-19 pandemic has caused an upturn in the supplements industry; from...
Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal.
Last year's R&D...
Extending skinspan with non-invasive senetherapeutic proprietary peptide.
OneSkin is a Longevity company on a mission to transform the way we think about skin. Today the...
![Ozone therapy recently hit the headlines as one of the many treatment options being examined to mitigate the effects of COVID-19 [1], but it is also showing great promise in the treatment of neurodegenerative conditions such as Alzheimer’s and Parkinson's.](https://www.longevity.technology/wp-content/uploads/2020/10/Ozone-therapyW-218x150.jpg "Stopping neurodegeneration in its tracks with ozone therapy")
